Erlotinib hydrochloride
 OpenBabel02212023462D

 30 31  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.9806    3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2661    3.3000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2661    2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5517    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5517    1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8372    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8372   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5517   -0.4125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2661   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9806   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6951   -0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4096   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1227   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4083   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6938   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6938   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9793   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9793   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2648   -2.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5504   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5504   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2648   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8359   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1214   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9793    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9793    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6938    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4083    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1227    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 30  1  0  0  0  0
  8  9  1  0  0  0  0
  8 14  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 29  1  0  0  0  0
 16 17  1  0  0  0  0
 16 26  2  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 18 23  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 22 24  1  0  0  0  0
 24 25  3  0  0  0  0
 26 27  1  0  0  0  0
 27 28  2  0  0  0  0
 28 29  1  0  0  0  0
 29 30  2  0  0  0  0
M  END
>  <CdId>
286

>  <Mol Weight>
429.897

>  <Formula>
C22H24ClN3O4

>  <ID>
T0373L

>  <Name>
Erlotinib hydrochloride

>  <Synonyms>
CP-358774;OSI-774;NSC 718781

>  <CAS>
183319-69-9

>  <Approved status>
FDA

>  <Disease>
Cancer

>  <Indication>
Non-Small Cell Lung Cancer

>  <Pathways>
Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors

>  <Target>
EGFR

>  <Receptor>
EGFR

$$$$
